Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HNF4A | P41235 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 5/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10349769 | 0.87 | ALDH1A1 (0.54) | LIG1ALDH1A1L3MBTL1MAPTLMNA | |
| SCHEMBL10339858 | 0.83 | KEAP1 (0.56) | LIG1ALDH1A1L3MBTL1KDM4EHSD17B10 | |
| SCHEMBL5128860 | 0.83 | KDM4E (0.58) | LIG1ALDH1A1L3MBTL1KDM4EHSD17B10 | |
| SCHEMBL9686151 | 0.82 | CASP3 (0.51) | LIG1ALDH1A1L3MBTL1MAPTLMNA | |
| Phthalic Acid SCHEMBL28249734 | 0.82 | GSK3B (0.65) | LIG1ALDH1A1L3MBTL1MAPTLMNA | |
| SCHEMBL11612938 | 0.81 | KDM4E (0.49) | LIG1ALDH1A1L3MBTL1MAPTKDM4E | |
| SCHEMBL10498838 | 0.81 | POLB (0.46) | LIG1ALDH1A1L3MBTL1MAPTLMNA | |
| SCHEMBL2823345 | 0.80 | KDM4E (0.47) | LIG1ALDH1A1L3MBTL1KDM4EHSD17B10 | |
| Phthalic Acid SCHEMBL28572075 | 0.80 | GSK3B (0.62) | LIG1ALDH1A1L3MBTL1MAPTLMNA | |
| SCHEMBL10967338 | 0.79 | KEAP1 (0.59) | LIG1ALDH1A1L3MBTL1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140322646-A1 | ABLATION IMAGEABLE LITHOGRAPHIC PRINTING PLATE | NPEC INC. | 2014-10-30 | — | — | US | claimed |
| US-20140065407-A1 | MANUFACTURE OF LITHOGRAPHIC PRINTING PLATE PRECURSORS FOR ABLATION IMAGING | KODAK REALTY INC. | 2014-03-06 | — | — | US | claimed |
| WO-2012106169-A1 | METHOD FOR PREPARING LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK COMPANY (US) | 2012-08-09 | — | — | WO | claimed |
| US-20120192741-A1 | METHOD FOR PREPARING LITHOGRAPHIC PRINTING PLATES | NPEC INC. | 2012-08-02 | — | — | US | claimed |
| WO-2012099833-A1 | PREPARING LITHOGRAPHIC PRINTING PLATES BY ABLATION IMAGING | EASTMAN KODAK COMPANY (US) | 2012-07-26 | — | — | WO | claimed |
| US-20120189770-A1 | PREPARING LITHOGRAPHIC PRINTING PLATES BY ABLATION IMAGING | KODAK REALTY INC. | 2012-07-26 | — | — | US | claimed |
| US-7138425-B2 | Phthalimide carboxylic acid derivatives | OXFORD GLYCOSCIENCE (UK) LTD. (GB) | 2006-11-21 | — | — | US | claimed |
| US-20050203153-A1 | Phthalimide carboxylic acid derivatives | OXFORD GLYCOSCIENCE (UK) LTD. (GB) | 2005-09-15 | — | — | US | claimed |
| JP-6239017-A | — | — | None | — | — | JP | disclosed |
| EP-3345055-B1 | LITHOGRAPHIC DEVELOPER COMPOSITION AND METHOD OF USE | EASTMAN KODAK CO (US) | 2019-09-18 | — | — | EP | disclosed |
| CN-110028439-A | Phthalimide analog derivative and its preparation method and application | 四川大学 | 2019-07-19 | — | — | CN | disclosed |
| WO-2018177861-A1 | SYMMETRICAL TRIS-ARYL-AMIDE DERIVATIVES AND THEIR USE AS ANTI-HEPARANASE | LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE (CH) | 2018-10-04 | — | — | WO | disclosed |
| EP-3381898-A1 | SYMMETRICAL TRIS-ARYL-AMIDE DERIVATIVES AND THEIR USE AS ANTI-HEPARANASE | Leadiant Biosciences SA (CH) | 2018-10-03 | — | — | EP | disclosed |
| EP-3345055-A1 | LITHOGRAPHIC DEVELOPER COMPOSITION AND METHOD OF USE | Eastman Kodak Company (US) | 2018-07-11 | — | — | EP | disclosed |
| US-4306072-A | ANXIOLYTIC AND PSYCHOSTIMULANT ACTIVITY FOR TREATMENT OF PSYCHOLOGICAL DISORDERS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE (FR) | 1981-12-15 | — | — | US | disclosed |
| US-4268512-A | ANXIOLYTIC AGENTS, PSYCHOSTIMULANTS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1981-05-19 | — | — | US | disclosed |
| US-4255580-A | TREATMENT OF PSYCHOLOGICAL DISORDERS | SIOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1981-03-10 | — | — | US | disclosed |
| US-4248885-A | FOR GASTROINTESTINAL, UROGENITAL, RHEUMATIC, AND CARDIOVASCULAR DISEASE | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1981-02-03 | — | — | US | disclosed |
| US-4229443-A | Derivatives of penicillanic acid | LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) | 1980-10-21 | — | — | US | disclosed |
| US-4186135-A | TREATMENT OF PSYCHOLOGICAL DISORDERS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203153-A1 | Phthalimide carboxylic acid derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, IDH1 | LIG1 2558/4885ALDH1A1 160/4885L3MBTL1 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.